Get the Stockscreener App
2.06
5.07%
-0.11
After Hours:
2.11
0.05
+2.43%
Pyxis Oncology Inc stock is traded at $2.06, with a volume of 497.44K.
It is down -5.07% in the last 24 hours and up +48.20% over the past month.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
See More
Previous Close:
$2.17
Open:
$2.13
24h Volume:
497.44K
Relative Volume:
0.76
Market Cap:
$127.76M
Revenue:
-
Net Income/Loss:
$-73.79M
P/E Ratio:
-1.1196
EPS:
-1.84
Net Cash Flow:
$-77.44M
1W Performance:
-11.21%
1M Performance:
+48.20%
6M Performance:
+79.13%
1Y Performance:
-41.31%
1-Day Range:
$2.03
$2.15
1-Week Range:
$2.03
$2.36
52-Week Range:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Name
Pyxis Oncology Inc
Sector
Industry
Phone
(617) 221-9059
Address
321 HARRISON AVENUE, BOSTON
Compare PYXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
2.06 | 134.58M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Nov-21-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-08-24 | Initiated | Stephens | Overweight |
| Aug-08-24 | Initiated | Stifel | Buy |
| May-07-24 | Resumed | Jefferies | Buy |
| Feb-09-24 | Initiated | BTIG Research | Buy |
| Jan-23-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-21 | Initiated | BofA Securities | Neutral |
| Nov-02-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Jefferies | Buy |
View All
Pyxis Oncology Inc Stock (PYXS) Latest News
Live market analysis of Pyxis Oncology Inc.July 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Quantitative breakdown of Pyxis Oncology Inc. recent moveJuly 2025 Closing Moves & High Yield Stock Recommendations - newser.com
What to do if you’re stuck in Pyxis Oncology Inc.Quarterly Investment Review & Safe Entry Momentum Tips - newser.com
Can swing trading help recover from Pyxis Oncology Inc. lossesJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com
Detecting support and resistance levels for Pyxis Oncology Inc.2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
How institutional ownership impacts Pyxis Oncology Inc. stockJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Sector ETF performance correlation with Pyxis Oncology Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from S&P Global BMI Index - MarketScreener
Will Pyxis Oncology Inc. rebound enough to break evenJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
How hedge fund analytics apply to Pyxis Oncology Inc. stock2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
How Pyxis Oncology Inc. stock performs in rising dollar environment2025 Performance Recap & Fast Momentum Entry Tips - newser.com
AI Stocks: Can Pyxis Oncology Inc expand its profit margins2025 EndofYear Setup & Growth Focused Investment Plans - khodrobank.com
Is Pyxis Oncology Inc. meeting your algorithmic filter criteriaQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
How to build a dashboard for Pyxis Oncology Inc. stockJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Pyxis Oncology Inc. stock trend forecastJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Analyzing Pyxis Oncology Inc. with multi timeframe chartsAnalyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
Bank Watch: Can Pyxis Oncology Inc sustain its profitabilityJuly 2025 Reactions & Precise Buy Zone Tips - خودرو بانک
News impact scoring models applied to Pyxis Oncology Inc.Weekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
What candlestick patterns are forming on Pyxis Oncology Inc.Market Risk Analysis & Weekly High Potential Stock Alerts - newser.com
Published on: 2025-09-18 16:46:44 - newser.com
Aug Retail: Can Pyxis Oncology Inc. grow without external fundingQuarterly Portfolio Summary & AI Based Trade Execution Alerts - khodrobank.com
Pyxis Oncology Inc (NASDAQ: PYXS) Yet To Convince Analysts? - stocksregister.com
What momentum shifts mean for Pyxis Oncology Inc.2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
What technical models suggest about Pyxis Oncology Inc.’s comebackDay Trade & Fast Momentum Entry Tips - newser.com
Technical analysis overview for Pyxis Oncology Inc. stockQuarterly Growth Report & Expert Approved Momentum Ideas - newser.com
Setup Watch: Is Pyxis Oncology Inc. part of any ETFEarnings Recap Summary & Safe Capital Growth Plans - khodrobank.com
EV Market: Is Manhattan Associates Inc a speculative investmentJuly 2025 Momentum & Consistent Return Strategy Ideas - خودرو بانک
Aug Patterns: Can Pyxis Oncology Inc. grow without external fundingForecast Cut & Detailed Earnings Play Strategies - خودرو بانک
Recap Report: Will LMNR benefit from government policyWeekly Risk Report & Advanced Technical Analysis Signals - khodrobank.com
Should You Buy Pyxis Oncology, Inc. (PYXS) After Golden Cross? - Zacks Investment Research
Building trade automation scripts for Pyxis Oncology Inc.2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
What moving averages say about Pyxis Oncology Inc.New Guidance & Smart Money Movement Alerts - newser.com
Pyxis Oncology Inc Stock (PYXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):